MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
Authors
Keywords
-
Journal
CURRENT OPINION IN INFECTIOUS DISEASES
Volume 36, Issue 6, Pages 564-571
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-11-06
DOI
10.1097/qco.0000000000000966
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
- (2023) Alexis Tabah et al. INTENSIVE CARE MEDICINE
- Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study
- (2023) Qing Yuan et al. Frontiers in Microbiology
- Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
- (2023) Jinnethe Reyes et al. Lancet Microbe
- Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa
- (2022) Cristina Lasarte-Monterrubio et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
- (2022) Marta Hernández-García et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
- (2021) Mical Paul et al. CLINICAL MICROBIOLOGY AND INFECTION
- A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
- (2020) Ivan Titov et al. CLINICAL INFECTIOUS DISEASES
- External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection using Electronic Health Record Data from 140 US Hospitals
- (2019) Sameer S Kadri et al. Open Forum Infectious Diseases
- DTR, do we need a new definition?
- (2019) Roger M Echols et al. CLINICAL INFECTIOUS DISEASES
- RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
- (2019) Johann Motsch et al. CLINICAL INFECTIOUS DISEASES
- Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
- (2019) Maddalena Giannella et al. Open Forum Infectious Diseases
- Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers
- (2017) Tommaso Giani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?
- (2012) Konstantinos Z. Vardakas et al. JOURNAL OF INFECTION
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now